Latest
Novel combination therapy improves progression-free survival in most common form of metastatic breast cancer
Patients with estrogen receptor–positive, HER2-negative advanced breast cancer experienced significantly longer progression-free survival when treated with an oral combination therapy that included giredestrant, a next-generation selective estrogen receptor degrader and…
Popular
Biomedical Advances
Novel combination therapy improves progression-free survival in most common form of metastatic breast cancer
Patients with estrogen receptor–positive, HER2-negative advanced breast cancer experienced significantly longer progression-free survival when treated with an oral combination therapy that included giredestrant, a next-generation selective estrogen receptor degrader and…
Diet and Lifestyle
Less ultra-processed food and more physical activity lower type 2 diabetes risk, regardless of genetics
Eating fewer ultra-processed foods and exercising regularly may lower the risk of type 2 diabetes—even among people with a strong genetic predisposition to the disease. …
Preventive Medicine
Artificial intelligence model predicts pancreatic cancer risk 3 years before diagnosis
An artificial intelligence model uses routine health records to predict an individual’s risk of developing pancreatic cancer several years before diagnosis. …
